Cancer Biotechnology

Cancer is that the degeneration of one kind of cell within an organism into something anarchistically powerful, and nasty. As this new cell-form uncontrollably proliferates and embeds itself during a tissue host, a tumor is born. Once tumor cells later spread, the prognosis for its victim rapidly diminishes, a process known as metastasis. Detected at an early stage, cancer is benign and solvable. However once metastases appear the challenge becomes a full new (depressingly difficult) ball-game. Research targeted on understanding the molecular mechanisms of cancer, and developing diagnostics and drugs for its cure. The foremost cross-disciplinary of contemporary research areas, cancer biotechnology research involves scientists from medicine, biology, physics and engineering disciplines.


    Related Conference of Cancer Biotechnology

    June 16-17, 2022

    26th Biotechnology Congress: Research & Innovations

    Vancouver, Canada
    June 29-29, 2022

    26th World Congress on Pharmaceutical Biotechnology

    Singapore City, Singapore
    August 01-02, 2022

    3rd World Congress on Food Science and Biotechnology

    Zurich, Switzerland
    August 25-26, 2022

    3nd International Conference on Biotechnology and Healthcare

    Hong Kong, Hong Kong
    August 25-25, 2022

    28th Asia Pacific Biotechnology Congress

    Singapore City, Singapore
    October 20-21, 2022

    25th Global Biotechnology Congress

    Dubai, UAE
    November 14-15, 2022

    6th International Conference on Protein Engineering

    London, UK
    November 16-17, 2022

    27th World Congress on Industrial Biotechnology

    Tokyo, Japan
    November 21-22, 2022

    7th International Conference on Bioscience and Biotechnology

    Singapore City, Singapore

    Cancer Biotechnology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in